BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 7883981)

  • 1. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.
    Jonkman MF; de Jong MC; Heeres K; Pas HH; van der Meer JB; Owaribe K; Martinez de Velasco AM; Niessen CM; Sonnenberg A
    J Clin Invest; 1995 Mar; 95(3):1345-52. PubMed ID: 7883981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency.
    Jonkman MF; de Jong MC; Heeres K; Steijlen PM; Owaribe K; Küster W; Meurer M; Gedde-Dahl T; Sonnenberg A; Bruckner-Tuderman L
    Arch Dermatol; 1996 Feb; 132(2):145-50. PubMed ID: 8629821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion--reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes.
    Borradori L; Chavanas S; Schaapveld RQ; Gagnoux-Palacios L; Calafat J; Meneguzzi G; Sonnenberg A
    Exp Cell Res; 1998 Mar; 239(2):463-76. PubMed ID: 9521865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 180-kDa bullous pemphigoid antigen defective generalized atrophic benign epidermolysis bullosa: report of four cases with an unusually mild phenotype.
    Mazzanti C; Gobello T; Posteraro P; Paradisi M; Meneguzzi G; Chinni L; Zambruno G
    Br J Dermatol; 1998 May; 138(5):859-66. PubMed ID: 9666835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Herlitz junctional epidermolysis bullosa without hair involvement associated with BP180 deficiency.
    Guerriero C; De Simone C; Venier A; Rotoli M; Posteraro P; Zambruno G; Amerio P
    Dermatology; 2001; 202(1):58-62. PubMed ID: 11244233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa.
    Pohla-Gubo G; Lazarova Z; Giudice GJ; Liebert M; Grassegger A; Hintner H; Yancey KB
    Exp Dermatol; 1995 Aug; 4(4 Pt 1):199-206. PubMed ID: 8535614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa.
    Darling TN; McGrath JA; Yee C; Gatalica B; Hametner R; Bauer JW; Pohla-Gubo G; Christiano AM; Uitto J; Hintner H; Yancey KB
    J Invest Dermatol; 1997 Apr; 108(4):463-8. PubMed ID: 9077475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mosaic expression of uncein and 180-kDa bullous pemphigoid antigen in generalized atrophic benign epidermolysis bullosa.
    Matsumura Y; Horiguchi Y; Toda K; Fujii H; Kore-Eda S; Tachibana T; Ohta K; Okamoto H; Imamura S
    Br J Dermatol; 1997 May; 136(5):757-61. PubMed ID: 9205513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa.
    Pulkkinen L; Marinkovich MP; Tran HT; Lin L; Herron GS; Uitto J
    J Invest Dermatol; 1999 Dec; 113(6):1114-8. PubMed ID: 10636730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa.
    Chavanas S; Gache Y; Tadini G; Pulkkinen L; Uitto J; Ortonne JP; Meneguzzi G
    J Invest Dermatol; 1997 Jul; 109(1):74-8. PubMed ID: 9204958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAD-1 is absent in a subset of junctional epidermolysis bullosa patients.
    Marinkovich MP; Tran HH; Rao SK; Giudice GJ; Balding S; Jonkman MF; Pas HH; McGuire JS; Herron GS; Bruckner-Tuderman L
    J Invest Dermatol; 1997 Sep; 109(3):356-9. PubMed ID: 9284104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BP180/type XVII collagen: its role in acquired and inherited disorders or the dermal-epidermal junction.
    Zillikens D; Giudice GJ
    Arch Dermatol Res; 1999 Apr; 291(4):187-94. PubMed ID: 10335914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex.
    Huber M; Floeth M; Borradori L; Schäcke H; Rugg EL; Lane EB; Frenk E; Hohl D; Bruckner-Tuderman L
    J Invest Dermatol; 2002 Jan; 118(1):185-92. PubMed ID: 11851893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex.
    Fontao L; Tasanen K; Huber M; Hohl D; Koster J; Bruckner-Tuderman L; Sonnenberg A; Borradori L
    J Invest Dermatol; 2004 Jan; 122(1):65-72. PubMed ID: 14962091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BP180 gene delivery in junctional epidermolysis bullosa.
    Seitz CS; Giudice GJ; Balding SD; Marinkovich MP; Khavari PA
    Gene Ther; 1999 Jan; 6(1):42-7. PubMed ID: 10341874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Academy of Dermatology 1997 Awards for Young Investigators in Dermatology. Mutational analysis of the bullous pemphigoid antigen 2/type XVII collagen gene in patients with generalized atrophic benign epidermolysis bullosa.
    Darling TN
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):773-4. PubMed ID: 9366826
    [No Abstract]   [Full Text] [Related]  

  • 17. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1.
    Shimizu H; Takizawa Y; Pulkkinen L; Zone JJ; Matsumoto K; Saida T; Uitto J; Nishikawa T
    J Invest Dermatol; 1998 Nov; 111(5):887-92. PubMed ID: 9804354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
    Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
    Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
    Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U
    J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining target antigens in linear IgA disease using skin from subjects with inherited epidermolysis bullosa as a substrate for indirect immunofluorescence microscopy.
    Harman KE; Bhogal BS; Eady RA; McGrath JA; Black MM
    Br J Dermatol; 1999 Sep; 141(3):475-80. PubMed ID: 10583051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.